Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease
Academic Article
Publication Date:
2020
Short description:
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease / Gonzalez-Cordon, Ana; Assoumou, Lambert; Camafort, Miguel; Domenech, Monica; Guaraldi, Giovanni; Domingo, Pere; Rusconi, Stefano; Raffi, François; Katlama, Christine; Masia, Mar; I Bernardino, Jose; Saumoy, Maria; Pozniak, Anton; M Gatell, Jose; Martinez, Esteban. - In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. - ISSN 0305-7453. - 75:11(2020), pp. 3334-3343. [10.1093/jac/dkaa292]
Iris type:
Articolo su rivista
List of contributors:
Gonzalez-Cordon, Ana; Assoumou, Lambert; Camafort, Miguel; Domenech, Monica; Guaraldi, Giovanni; Domingo, Pere; Rusconi, Stefano; Raffi, François; Katlama, Christine; Masia, Mar; I Bernardino, Jose; Saumoy, Maria; Pozniak, Anton; M Gatell, Jose; Martinez, Esteban
Published in: